Total Payments
$154,325
2024 Payments
$12,174
Companies
14
Transactions
138
Medicare Patients
2,953
Medicare Billing
$627,945
Payment Breakdown by Category
Consulting$83,793 (54.3%)
Other$41,446 (26.9%)
Research$16,552 (10.7%)
Travel$8,540 (5.5%)
Food & Beverage$3,995 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $83,793 | 35 | 54.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $27,950 | 16 | 18.1% |
| Unspecified | $16,552 | 9 | 10.7% |
| Honoraria | $13,496 | 11 | 8.7% |
| Travel and Lodging | $8,540 | 20 | 5.5% |
| Food and Beverage | $3,995 | 47 | 2.6% |
Payments by Type
General
$137,773
129 transactions
Research
$16,552
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $59,153 | 53 | $0 (2024) |
| VIEWRAY TECHNOLOGIES INC | $55,206 | 45 | $0 (2022) |
| Varian Medical Systems, Inc. | $15,697 | 13 | $0 (2020) |
| Genentech, Inc. | $11,537 | 8 | $0 (2024) |
| AstraZeneca UK Limited | $5,299 | 3 | $0 (2022) |
| F. Hoffmann-La Roche AG | $4,785 | 3 | $0 (2024) |
| Siemens Medical Solutions USA, Inc. | $2,285 | 6 | $0 (2024) |
| Elekta, Inc. | $167.26 | 1 | $0 (2021) |
| Amgen Inc. | $79.60 | 1 | $0 (2024) |
| Zap Surgical Systems, Inc. | $50.68 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,174 | 19 | AstraZeneca Pharmaceuticals LP ($5,347) |
| 2023 | $6,730 | 9 | AstraZeneca Pharmaceuticals LP ($3,190) |
| 2022 | $31,195 | 28 | VIEWRAY TECHNOLOGIES INC ($21,622) |
| 2021 | $22,469 | 14 | VIEWRAY TECHNOLOGIES INC ($11,700) |
| 2020 | $13,622 | 10 | VIEWRAY TECHNOLOGIES INC ($6,000) |
| 2019 | $18,134 | 17 | AstraZeneca Pharmaceuticals LP ($7,309) |
| 2018 | $22,393 | 21 | AstraZeneca Pharmaceuticals LP ($18,108) |
| 2017 | $27,608 | 20 | AstraZeneca Pharmaceuticals LP ($13,454) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Genentech, Inc. | Tecentriq (Biological) | — | Cash or cash equivalent | $1,041.70 | Research |
| Study: Tiragolumab Tecentriq vs Durvalumab in Unresectable Stage III NSCLC • Category: BioOncology | ||||||
| 12/04/2024 | Siemens Medical Solutions USA, Inc. | MicroThermX Microwave Ablation System (Device) | Food and Beverage | In-kind items and services | $31.09 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $79.60 | General |
| Category: Oncology | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,730.00 | General |
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $134.44 | General |
| Category: Oncology | ||||||
| 09/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $121.66 | General |
| 09/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.76 | General |
| 08/20/2024 | F. Hoffmann-La Roche AG | Alecensa (Biological) | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| Category: BioOncology | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $103.44 | General |
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $134.57 | General |
| 07/12/2024 | icotec Medical Inc. | icotec BlackArmor Spine System (Device) | Food and Beverage | Cash or cash equivalent | $14.51 | General |
| Category: Spine stabilization for spine patients | ||||||
| 07/05/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,510.00 | General |
| 06/03/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Travel and Lodging | In-kind items and services | $379.20 | General |
| Category: Oncology | ||||||
| 06/03/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Oncology | ||||||
| 06/02/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $77.80 | General |
| 05/23/2024 | Genentech, Inc. | Tecentriq (Biological) | — | Cash or cash equivalent | $781.25 | Research |
| Study: Tiragolumab Tecentriq vs Durvalumab in Unresectable Stage III NSCLC • Category: BioOncology | ||||||
| 02/20/2024 | F. Hoffmann-La Roche AG | Alecensa (Biological) | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| Category: BioOncology | ||||||
| 01/26/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: HORMONE THERAPY | ||||||
| 01/24/2024 | Genentech, Inc. | Tecentriq (Biological) | — | Cash or cash equivalent | $1,562.50 | Research |
| Study: Tiragolumab Tecentriq vs Durvalumab in Unresectable Stage III NSCLC • Category: BioOncology | ||||||
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $2,642.50 | General |
| Category: Oncology | ||||||
| 10/04/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Travel and Lodging | In-kind items and services | $333.58 | General |
| Category: Oncology | ||||||
| 10/04/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $103.75 | General |
| Category: Oncology | ||||||
| 09/23/2023 | Siemens Medical Solutions USA, Inc. | Varian CRYOCARE TOUCH System (Device) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Oncology | ||||||
| 08/24/2023 | Siemens Medical Solutions USA, Inc. | Varian Ethos Treatment Planning (Device) | Food and Beverage | In-kind items and services | $151.47 | General |
| Category: Oncology | ||||||
| 08/22/2023 | F. Hoffmann-La Roche AG | Alecensa (Biological) | Consulting Fee | Cash or cash equivalent | $1,485.00 | General |
| Category: BioOncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| SMART Pancreas Trial | VIEWRAY TECHNOLOGIES INC | $6,500 | 2 |
| Tiragolumab Tecentriq vs Durvalumab in Unresectable Stage III NSCLC | Genentech, Inc. | $5,260 | 4 |
| TIRAGOLUMAB TECENTRIQ VS DURVALUMAB IN UNRESECTABLE STAGE III NSCLC | Genentech, Inc. | $4,792 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,339 | 3,838 | $1.6M | $341,451 |
| 2022 | 11 | 368 | 814 | $374,861 | $69,438 |
| 2021 | 14 | 601 | 1,470 | $1.1M | $106,058 |
| 2020 | 17 | 645 | 1,680 | $1.2M | $110,998 |
Total Patients
2,953
Total Services
7,802
Medicare Billing
$627,945
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 112 | 459 | $533,358 | $74,498 | 14.0% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 126 | 1,863 | $288,765 | $70,327 | 24.4% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 116 | 128 | $200,321 | $45,667 | 22.8% |
| 77435 | Management of cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 46 | 61 | $112,639 | $33,308 | 29.6% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 125 | 135 | $91,253 | $25,862 | 28.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 170 | 170 | $94,690 | $25,561 | 27.0% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 133 | 142 | $88,625 | $20,073 | 22.6% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 127 | 432 | $53,136 | $12,128 | 22.8% |
| 77470 | Special radiation treatment | Office | 2023 | 121 | 126 | $52,164 | $11,481 | 22.0% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 130 | 157 | $38,465 | $8,070 | 21.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 99 | $25,344 | $8,001 | 31.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 28 | $10,640 | $3,370 | 31.7% |
| 77293 | Obtaining respiratory data needed to develop the optimal radiation treatment | Office | 2023 | 21 | 22 | $6,693 | $1,977 | 29.5% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 15 | 16 | $4,976 | $1,128 | 22.7% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2022 | 32 | 82 | $97,854 | $13,449 | 13.7% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2022 | 28 | 316 | $48,980 | $12,251 | 25.0% |
| 77301 | High precision radiation therapy planning | Office | 2022 | 26 | 26 | $31,736 | $9,430 | 29.7% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2022 | 29 | 31 | $20,954 | $6,045 | 28.8% |
| 77263 | Complex radiation therapy planning | Office | 2022 | 34 | 35 | $19,230 | $5,066 | 26.3% |
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2022 | 11 | 27 | $38,313 | $4,250 | 11.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $14,432 | $3,693 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 33 | 43 | $10,793 | $2,849 | 26.4% |
| 77470 | Special radiation treatment | Office | 2022 | 28 | 28 | $12,483 | $2,592 | 20.8% |
| 77300 | Calculation of radiation therapy dose | Office | 2022 | 32 | 81 | $10,431 | $2,282 | 21.9% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2022 | 35 | 43 | $12,259 | $2,237 | 18.3% |
About Dr. Percy Lee, M.D
Dr. Percy Lee, M.D is a Radiation Oncology healthcare provider based in Irvine, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1447442504.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Percy Lee, M.D has received a total of $154,325 in payments from pharmaceutical and medical device companies, with $12,174 received in 2024. These payments were reported across 138 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($83,793).
As a Medicare-enrolled provider, Lee has provided services to 2,953 Medicare beneficiaries, totaling 7,802 services with total Medicare billing of $627,945. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Other Specialties Radiation Oncology
- Location Irvine, CA
- Active Since 08/13/2007
- Last Updated 06/06/2022
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1447442504
Products in Payments
- IMFINZI (Drug) $40,367
- MRIdian (Device) $24,314
- MRIdian LINAC (Device) $21,622
- OTHER (Device) $14,152
- IMFINZI (Biological) $11,699
- MRIDIAN (Device) $6,770
- Alecensa (Biological) $6,270
- Tecentriq (Biological) $5,260
- TECENTRIQ (Biological) $4,792
- TAGRISSO (Drug) $3,775
- TrueBeam (Device) $2,285
- Treatment Planning Systems (Device) $450.00
- ELEKTA UNITY (Device) $167.26
- Varian Ethos Treatment Planning (Device) $151.47
- Blincyto (Biological) $79.60
- ZAP-X MV IMAGER (Device) $50.68
- MicroThermX Microwave Ablation System (Device) $31.09
- LILETTA (Drug) $19.41
- Varian CRYOCARE TOUCH System (Device) $17.62
- ORGOVYX (Drug) $16.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Radiation Oncology Doctors in Irvine
Dr. Kenneth Tokita, M.d, M.D
Radiation Oncology — Payments: $19,473
Radiation Oncology $19,473
Selamawit Negusse, Md, MD
Radiation Oncology — Payments: $1,611
Radiation Oncology $1,611
Dr. Harry Moyses, M.d, M.D
Radiation Oncology — Payments: $886.24
Radiation Oncology $886.24
Dr. Amanda Schwer, Md, MD
Radiation Oncology — Payments: $495.28
Radiation Oncology $495.28
Judith Harrison-Monge-Reiner, M.d, M.D
Radiation Oncology — Payments: $38.04
Radiation Oncology $38.04
Dr. Julius Weng, M.d, M.D
Radiation Oncology
Radiation Oncology